Facility Operations PDF Print E-mail
Friday, 08 May 2009 06:35

 

Our production facility is operated under the strict governance of quality control standards which meet or exceed those required by governmental oversight. The facility itself is divided into many areas, each serving a specific purpose. They are loosely categorized into two identifiable groupings: storage and production.


General Facility Organization


The storage facility is utilized at several points during the production process, serving as:


  • Bulk ingredient and materials storage and quarantine
  • Bulk product storage and quarantine (of finished, but not yet packaged tablets)
  • Finished product quarantine storage (pending final testing and approval), and
  • Finished, market-ready product storage

  • The production facility is also further divided into two general productions lines:


  • Oral pharmaceutical production
  • Oral pharmaceutical packaging
  • Injectable pharmaceutical production
  • Injectable container sterilization
  • Injectable pharmaceutical packaging

  • We are in the process of expanding the pharmaceutical production facility to double the production capacity for all product lines.


    The Production Process


    Generally speaking, the production of sterile pharmaceuticals is a six stage process:


  • Acquisition and acceptance of bulk raw materials
  • Pre-production preparation and planning
  • Pharmaceutical component manufacturing
  • Pharmaceutical component packaging
  • Post-production storage and testing
  • Delivery of finished product to distribution network
  •  

     
    Russian (CIS)Ukrainian (Ukraine)English (United Kingdom)